Results 21 to 30 of about 9,116 (181)
IDCases, 2022 Mycobacterium abscessus is one of the nontuberculous mycobacteria (NTM), which can cause many clinical spectra, predominantly pulmonary infections followed by skin and soft tissue infections.
Abdulrahman F. Al-Mashdali +4 more
doaj +1 more source
A first case report of nasopharyngeal Mycobacterium abscessus subspecies massiliense infection
European Journal of Medical Research, 2021 Background Mycobacterium abscessus subspecies massiliense is a non-tuberculous mycobacteriosis and was subdivided from Mycobacterium abscessus in 2006.
Yamato Oki +7 more
doaj +1 more source
A case of intrathoracic desmoid tumor with pulmonary Mycobacterium abscessus disease
Respiratory Medicine Case Reports, 2020 A 68-year-old man who was on treatment for pulmonary Mycobacterium avium complex complained a worsening of sputum. Although he archived negative sputum culture two months ago, sputum culture tests revealed the newly isolation of Mycobacterium abscessus ...
Takuma Katano +6 more
doaj +1 more source
Sitafloxacin Expresses Potent Anti-Mycobacterium abscessus Activity
Frontiers in Microbiology, 2022 Therapeutic options for treating Mycobacterium abscessus infections are extremely limited; quinolones are important. The in vitro anti-M. abscessus activities of nine quinolones, emphasizing sitafloxacin, were investigated.
Siyuan He +12 more
doaj +1 more source
Treatment of Mycobacterium abscessus Complex [PDF]
Seminars in Respiratory and Critical Care Medicine, 2018 AbstractOf the nontuberculous mycobacteria (NTMs) causing lung disease, members of the Mycobacterium abscessus complex (MABc) present a formidable obstacle to successful management. This challenge starts from a poorly understood pathogenesis, continues with complicated subspecies variation in treatment response, and extends to the multidrug-resistant ...
Luke, Strnad, Kevin L, Winthrop
openaire +2 more sources
Mycobacterium abscessus peritonitis and ventriculitis associated with ventriculoperitoneal shunt
IDCases, 2022 Mycobacterium abscessus, like most nontuberculous mycobacteria, is a pervasive organism. It frequently presents as a healthcare-associated infection. Mycobacterium abscessus infections are notoriously difficult to treat, requiring multidrug regimens and ...
D. Clabots, A. Serrat
doaj +1 more source
Population heterogeneity in Mycobacterium smegmatis and Mycobacterium abscessus
Microbiology, 2023 Bacteria use population heterogeneity, the presence of more than one phenotypic variant in a clonal population, to endure diverse environmental challenges – a ‘bet-hedging’ strategy. Phenotypic variants have been described in many bacteria, but the phenomenon is not well-understood in mycobacteria, including the environmental factors that influence ...
Sarah E. M. Born +5 more
openaire +2 more sources
Mycobacterium abscessus: It’s Complex
Microorganisms, 2022 Mycobacterium abscessus (M. abscessus) is an opportunistic pathogen usually colonizing abnormal lung airways and is often seen in patients with cystic fibrosis. Currently, there is no vaccine available for M. abscessus in clinical development. The treatment of M.
Hazem F. M. Abdelaal +4 more
openaire +3 more sources
Mycobacterium abscessus Ventriculoperitoneal Shunt Infection [PDF]
Cureus, 2021 Mycobacterium abscessus is a rapidly growing mycobacterium (RGM) known to be abundant in soil, dust and water. Unlike other non-tuberculous mycobacteria, RGM is typically resistant to first-line anti-tuberculosis drugs. These organisms are known to cause community and hospital-acquired infections; however, central nervous system (CNS) infections caused
Herrera, Danay +6 more
openaire +2 more sources
Rifabutin Is Inactivated by Mycobacterium abscessus Arr
Antimicrobial Agents and Chemotherapy, 2021 Mycobacterium abscessus exhibits arr (ADP-ribosyltransferase)-dependent rifampin resistance. In apparent contrast, rifabutin (RBT) has demonstrated promising activity in M. abscessus infection models, implying that RBT might not be inactivated by Arr.
Daniel Schäfle +6 more
openaire +3 more sources